Literature DB >> 1316530

Acute and late disease induced by murine coronavirus, strain JHM, in a series of recombinant inbred strains between BALB/cHeA and STS/A mice.

S Kyuwa1, K Yamaguchi, Y Toyoda, K Fujiwara, J Hilgers.   

Abstract

To examine the genetic control of acute and late disease induced by a murine coronavirus, strain JHM (JHMV), BALB/cHeA, STS/A, F1 hybrids and 13 recombinant inbred (RI) strains between BALB/cHeA and STS/A mouse strains were inoculated intracerebrally with 100 pfu of JHMV. All the BALB/cHeA mice died within 2 weeks from acute encephalitis. In contrast, STS/A mice were shown to be partially resistant, with a mortality rate of 30%, longer survival times and lower rates of viral production. The mortality rates, survival times and viral titers of F1 hybrids and the RI strains varied, suggesting involvement of multiple genes. STS/A, F1 hybrid and RI mice surviving the acute infection occasionally developed severe paraparesis about 1 month post-infection. In these mice, vacuolar degeneration, astrocytosis, the absence of perivascular cuffing and minimal demyelination were found in the central nervous system. No infectious virus could be recovered from these mice. Although the paralysis of delayed onset was limited to STS/A, F1 hybrid and eight of the 13 RI strains, the incidence varied significantly among the RI strains. These results may suggest that JHMV-induced late disease is also under multifactorial control. The pathogenesis of JHMV infection is discussed.

Entities:  

Mesh:

Year:  1992        PMID: 1316530      PMCID: PMC7135109          DOI: 10.1016/0882-4010(92)90112-2

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  33 in total

1.  Neuropathogenicity of mutant strains of mouse hepatitis virus, JHM.

Authors:  N Goto; Y Tsutsumi; A Sato; K Fujiwara
Journal:  Nihon Juigaku Zasshi       Date:  1987-10

2.  Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies.

Authors:  J O Fleming; M D Trousdale; F A el-Zaatari; S A Stohlman; L P Weiner
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

Review 3.  The biology and pathogenesis of coronaviruses.

Authors:  H Wege; S Siddell; V ter Meulen
Journal:  Curr Top Microbiol Immunol       Date:  1982       Impact factor: 4.291

4.  A series of recombinant inbred strains between the BALB/cHeA and STS/A mouse strains.

Authors:  J Hilgers; J Arends
Journal:  Curr Top Microbiol Immunol       Date:  1985       Impact factor: 4.291

5.  Site-specific alteration of murine hepatitis virus type 4 peplomer glycoprotein E2 results in reduced neurovirulence.

Authors:  R G Dalziel; P W Lampert; P J Talbot; M J Buchmeier
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

6.  Genetic study of mouse sensitivity to MHV3 infection: influence of the H-2 complex.

Authors:  E Lévy-Leblond; D Oth; J M Dupuy
Journal:  J Immunol       Date:  1979-04       Impact factor: 5.422

Review 7.  Neuroaxonal dystrophy: an ultrastructural link between subacute spongiform virus encephalopathies and Alzheimer's disease.

Authors:  P P Liberski; R Yanagihara; C J Gibbs; D C Gajdusek
Journal:  Prog Clin Biol Res       Date:  1989

8.  Protection of mice from a lethal coronavirus infection in the central nervous system by adoptive transfer of virus-specific T cell clones.

Authors:  K Yamaguchi; N Goto; S Kyuwa; M Hayami; Y Toyoda
Journal:  J Neuroimmunol       Date:  1991-04       Impact factor: 3.478

9.  The astrocyte is a target cell in mice persistently infected with mouse hepatitis virus, strain JHM.

Authors:  S Perlman; D Ries
Journal:  Microb Pathog       Date:  1987-10       Impact factor: 3.738

10.  Mouse hepatitis virus type 4 (JHM strains). induced fatal central nervous system disease. I. genetic control and murine neuron as the susceptible site of disease.

Authors:  R L Knobler; M V Haspel; M B Oldstone
Journal:  J Exp Med       Date:  1981-04-01       Impact factor: 14.307

View more
  6 in total

Review 1.  Murine coronavirus infection: a paradigm for virus-induced demyelinating disease.

Authors:  T E Lane; M J Buchmeier
Journal:  Trends Microbiol       Date:  1997-01       Impact factor: 17.079

Review 2.  Peripheral Neuropathies Derived from COVID-19: New Perspectives for Treatment.

Authors:  Alfredo Córdova-Martínez; Alberto Caballero-García; Daniel Pérez-Valdecantos; Enrique Roche; David César Noriega-González
Journal:  Biomedicines       Date:  2022-05-02

3.  Spread of a neurotropic coronavirus to spinal cord white matter via neurons and astrocytes.

Authors:  N Sun; S Perlman
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

4.  The Role of Host Genetic Factors in Coronavirus Susceptibility: Review of Animal and Systematic Review of Human Literature.

Authors:  Marissa LoPresti; David B Beck; Priya Duggal; Derek A T Cummings; Benjamin D Solomon
Journal:  medRxiv       Date:  2020-06-03

5.  Mice with different susceptibility to tick-borne encephalitis virus infection show selective neutralizing antibody response and inflammatory reaction in the central nervous system.

Authors:  Martin Palus; Jarmila Vojtíšková; Jiří Salát; Jan Kopecký; Libor Grubhoffer; Marie Lipoldová; Peter Demant; Daniel Růžek
Journal:  J Neuroinflammation       Date:  2013-06-27       Impact factor: 8.322

Review 6.  Of Mice and Men: The Coronavirus MHV and Mouse Models as a Translational Approach to Understand SARS-CoV-2.

Authors:  Robert W Körner; Mohamed Majjouti; Miguel A Alejandre Alcazar; Esther Mahabir
Journal:  Viruses       Date:  2020-08-12       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.